The language of antimicrobial and antibiotic resistance is blocking global collective action

被引:2
|
作者
Karvanen, Matti [1 ]
Cars, Otto [1 ]
机构
[1] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
关键词
Antibiotic resistance; antimicrobial resistance; narratives; behaviour change; policy; governance; microbiome;
D O I
10.1080/23744235.2024.2332455
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Sustainable access to effective antibiotics is a foundational need for functioning health care that is increasingly threatened by antibiotic resistance. Although resistance has been known as long as antibiotics have been in clinical use, there are still multiple gaps in the global and local responses. One often cited cause for this complacency is the language that is used to describe the problem and its consequences. In this paper, we survey some examples of the current discussions around antibiotic resistance and seek to offer a path towards unified and understandable messaging that is relevant both to the public and policymakers by using narratives that highlight the individual and societal consequences of antibiotic resistance. Major shortcomings in the current language that hamper both the understanding of antibiotic resistance and needed behaviour change have been identified in scientific papers and special reports. These shortcomings range from terminology that is difficult to understand, through a lack of personal relevance, to a fragmented response in the policy field. We propose that scientists, including behaviour change experts, and other key stakeholders that are engaged in the issue take lead to agreement on the core scientific facts and to formulate a vision that can be a foundation for creation of consistent global narratives. These narratives must in turn be adapted to local contexts. Development of such narratives should be viewed as an essential component in national action plans on AMR to raise awareness, empower citizens and incentivise societal behaviour change, policy development and implementation of governance structures.
引用
收藏
页码:487 / 495
页数:9
相关论文
共 50 条
  • [41] A Call for Action: The Application of the International Health Regulations to the Global Threat of Antimicrobial Resistance
    Wernli, Didier
    Haustein, Thomas
    Conly, John
    Carmeli, Yehuda
    Kickbusch, Ilona
    Harbarth, Stephan
    PLOS MEDICINE, 2011, 8 (04) : 6
  • [42] Antimicrobial Resistance: Addressing The Global Threat Through Greater Awareness And Transformative Action
    Keown, Oliver P.
    Warburton, Will
    Davies, Sally C.
    Darzi, Ara
    HEALTH AFFAIRS, 2014, 33 (09) : 1620 - 1626
  • [43] Antibiotic Use and Antimicrobial Resistance REPLY
    Alabiad, Chrisfouad R.
    Miller, Darlene
    Schiffman, Joyce C.
    Davis, Janet L.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (05) : 1011 - 1012
  • [44] Antimicrobial Resistance and Environmental Health: A Water Stewardship Framework for Global and National Action
    Kaiser, Rachel A.
    Taing, Lina
    Bhatia, Himesh
    ANTIBIOTICS-BASEL, 2022, 11 (01):
  • [45] ANTIMICROBIAL RESISTANCE - IMPLICATIONS FOR ANTIBIOTIC USE
    YOUNG, LS
    AMERICAN JOURNAL OF MEDICINE, 1986, 80 (5C): : 35 - 39
  • [46] Exploring antimicrobial resistance and antibiotic trends
    Chiodini, Jane
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2016, 14 (06) : 652 - 653
  • [47] Response to-Combating antimicrobial resistance demands nationwide action and global governance
    Gravatt, Lance
    NEW ZEALAND MEDICAL JOURNAL, 2016, 129 (1447) : 98 - 99
  • [48] Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action
    Wi, Teodora
    Lahra, Monica M.
    Ndowa, Francis
    Bala, Manju
    Dillon, Jo-Anne R.
    Ramon-Pardo, Pilar
    Eremin, Sergey R.
    Bolan, Gail
    Unemo, Magnus
    PLOS MEDICINE, 2017, 14 (07)
  • [49] A synthetic antibiotic overcomes antimicrobial resistance
    Marchal, Iris
    NATURE BIOTECHNOLOGY, 2024, 42 (03) : 379 - 379
  • [50] A synthetic antibiotic overcomes antimicrobial resistance
    Iris Marchal
    Nature Biotechnology, 2024, 42 : 379 - 379